Transactions
12
Insider / UNITEDHEALTH GROUP INC
Gottlieb Scott
Director at UNITEDHEALTH GROUP INC
- Company
- UNITEDHEALTH GROUP INC
- First filing on record
- November 5, 2025
- Latest trade on record
- October 1, 2026
- SEC filings
- EDGAR ↗
Gottlieb Scott, Director at UNITEDHEALTH GROUP INC, has disclosed 12 transactions in UNH, TEM, ILMN and 1 more since November 5, 2025: 2 purchases (2 open-market buys) and 0 sales, worth about $590K at the reported prices. The latest was filed October 5, 2026, 4 days after the trade; 3 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
2
Sales
0
Avg. disclosure lag
3.2d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Gottlieb Scott made 2 purchases worth $85K and no sales, plus 10 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Gottlieb Scott has traded 1 stock on record; the largest by dollars is ILMN.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
3 of 12 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 10 | 16,593 | $505K |
| P | Open-market purchase | 2 | 700 | $85K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 11 | 1 · $24K | 0 |
| 2025 | 1 | 1 · $61K | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| UNH | Other A | October 1, 2026 | October 5, 2026 | 4d | 257 | — | — | Form 4 ↗ | ||
| UNH | Other A | September 22, 2026 | September 24, 2026 | 2d | 5 | — | — | Form 4 ↗ | ||
| UNH | Other A | July 1, 2026 | July 6, 2026 | 5d | 210 | — | — | late | Form 4 ↗ | |
| UNH | Other A | June 23, 2026 | June 25, 2026 | 2d | 3 | — | — | Form 4 ↗ | ||
| TEM | Other A | May 21, 2026 | May 26, 2026 | 5d | 5,913 | — | — | late | Form 4 ↗ | |
| ILMN | Other A | May 21, 2026 | May 22, 2026 | 1d | 2,072 | $145 | $300K | Form 4 ↗ | ||
| PFE | Other A | April 23, 2026 | April 27, 2026 | 4d | 7,687 | $27 | $205K | derivative | Form 4 ↗ | |
| UNH | Other A | April 1, 2026 | April 6, 2026 | 5d | 320 | — | — | late | Form 4 ↗ | |
| UNH | Other A | March 17, 2026 | March 19, 2026 | 2d | 1 | — | — | Form 4 ↗ | ||
| ILMN | Buy P | February 9, 2026 | February 11, 2026 | 2d | 200 | $118 | $24K | Form 4 ↗ | ||
| UNH | Other A | January 2, 2026 | January 6, 2026 | 4d | 125 | — | — | Form 4 ↗ | ||
| ILMN | Buy P | November 3, 2025 | November 5, 2025 | 2d | 500 | $122 | $61K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 5, 2026 | Form 4 | 0000731766-26-000250 | 1 | published | EDGAR ↗ |
| September 24, 2026 | Form 4 | 0000731766-26-000230 | 1 | published | EDGAR ↗ |
| July 6, 2026 | Form 4 | 0000731766-26-000183 | 1 | published | EDGAR ↗ |
| June 25, 2026 | Form 4 | 0000731766-26-000168 | 1 | published | EDGAR ↗ |
| May 26, 2026 | Form 4 | 0001411359-26-000002 | 1 | published | EDGAR ↗ |
| May 22, 2026 | Form 4 | 0001110803-26-000115 | 1 | published | EDGAR ↗ |
| April 27, 2026 | Form 4 | 0001225208-26-004663 | 1 | published | EDGAR ↗ |
| April 6, 2026 | Form 4 | 0000731766-26-000113 | 1 | published | EDGAR ↗ |
| March 19, 2026 | Form 4 | 0000731766-26-000087 | 1 | published | EDGAR ↗ |
| February 11, 2026 | Form 4 | 0001110803-26-000022 | 1 | published | EDGAR ↗ |
| January 6, 2026 | Form 4 | 0000731766-26-000013 | 1 | published | EDGAR ↗ |
| November 5, 2025 | Form 4 | 0001110803-25-000076 | 1 | published | EDGAR ↗ |
Other insiders at UNITEDHEALTH GROUP INC
- LEFKOFSKY ERIC P CEO and Chairman 144 rows
- Meister Keith A. Director 111 rows
- NARAYEN SHANTANU Chair and CEO 88 rows
- Fukushima Ryan Chief Operating Officer 40 rows
- BOURLA ALBERT Chairman & CEO 34 rows
- Ullem Scott B. Director 31 rows
- Quincey James Chairman 29 rows
- Leckman Patricia SVP, Chief People Officer 17 rows
- Polovin Andrew EVP and General Counsel 17 rows
- NORA JOHNSON SUZANNE M Director 16 rows
Everyone on file, with contracts and lobbying under the company's name: UNITEDHEALTH GROUP INC.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 12 | 12 | November 5, 2025 | October 5, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.